cadenas

ITCC-073 NIVOLUMAB

  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-073 NIVOLUMAB

Pilot study of nivolumab in paediatric patients with hypermutant cancers

Promotor Name : BMS

Investigator Name : Dr Eric BOUFFET

Trial registered on clinicaltrial.gov: NCT02992964